AltraTech, a food diagnostics business, has banked €900,000 to help with the development of its high sensitivity species-specific identification device.
Concepta will now being to develop and market a diagnostic device for the testing of fertility, pregnancy and early-stage healthy pregnancy monitoring following a new funding round.
Investment firms TA Ventures and ABRT Venture Fund are coming together to lead a $2 million investment into healthcare booking platform Zesty.
A medical devices company based in Liverpool has become the latest business to receive equity backing from the government's Angel CoFund.
A business directed towards the developing of products for an ageing population has joined the AIM market of the London Stock Exchange.
Education technology start-up Meducation has courted the interest of a number of private investors in closing a $1 million seed funding round.
Healthcare business Futura Medical has used its AIM listing to raise new funds for growth of its sexual health and pain relief products.
Venture capital investor Octopus Investments has backed Michelson Diagnostics again through a £1.98 million round.
A seed funding round worth €750,000 has been closed by Irish business Metabolomic Diagnostics to help with growth.
The Business Growth Fund has continued with its active year-end dealmaking by investing in medical devices business Medicina.
An animal health, technical publishing and sustainability science business has joined London's Alternative Investment Market.
Specialist investor August Equity has made a new acquisition from its Partners III fund and added a social care business to its portfolio.
US-based investor Albion Ventures has expanded its SaaS portfolio by backing healthcare offering Cisiv.
Baird Capital portfolio company MedPlast has snapped up UK-based Orthoplastics for an undisclosed amount.
Scottish Equity Partners has closed its second deal in a week by investing in Aridhia Informatics alongside fellow VC Albion Ventures.
A new technology aimed improving the speed of surgical procedures has closed the first stage of a £2.5 million funding round.
A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.
Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.
The steady income streams and low risk profiles of pharmacy businesses are proving increasingly attractive for private equity investors, new figures suggest.
An eight-year involvement with dental membership plan business Practice Plan has netted Dunedin Private Equity a 2.8x return on its investment.
Britain has a track record of producing successful entrepreneurs, but which ones are doing particularly well?
With Regents Park Partners II ECF bringing the total amount of Enterprise Capital Funds to 16, where does the money lie and what it is targeting?
With March IPOs raising £671 million on London's AIM market, it looks like the junior exchange is back to its best.